RxDoctor Payments Data

Michael Argenziano, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · New York, NYNPI 1922042332

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $7,950 of the $11,975 with a category attached, or 66.4%. Medtronic accounts for 70.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $4,525 and has fallen 92.6% since, to $336 in 2025.

$11,975in general payments, 2019–2025

Across 49 payments — averaging $244.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$8K
  • Clearflow Inc.$1K
  • Abbott$951
  • Edwards Lifesciences$650
  • Abiomed$410
  • Baxter Healthcare$231
  • plus $271 from 6 others
$183,920in research payments, 2019–2025

Across 13 payments — averaging $14,148 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vascular Graft Solutions Inc$135K
  • Genentech, Inc.$28K
  • Artivion, Inc.$21K

What the payments were for

  • Speaking & faculty fees$7,95066%
  • Food & beverage$4,02534%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)5$8,411
Clearflow Inc.2$1,051
Abbott10$951
Edwards Lifesciences14$650
Abiomed6$410
Baxter Healthcare5$231
Boehringer Ingelheim1$125
Convatec Inc.2$41
Monteris Medical Corporation1$31
Guard Medical Inc.1$30
Davol Inc.1$29
Johnson & Johnson1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,975 in reported general payments places this provider in the 70th percentile of 383 thoracic surgery (cardiothoracic vascular surgery) providers in New York.

See all thoracic surgery (cardiothoracic vascular surgery) providers in New York

Medicare billing

Part B allowed, 2024
$111,015
Medicare patients
74
Services billed
147

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →